Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis’ Data-Centric R&D Strategy Adds Pact With UK-based Big Data Institute

Executive Summary

Novartis and the Big Data Institute have entered a research alliance using artificial intelligence to understand complex diseases and improve drug development.

You may also be interested in...



Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits

Novartis executives highlighted their stars from its refined pipeline during the company’s first R&D day since Vas Narasimhan took the helm and after a cull that reduced the firm’s development portfolio by 20%.

Novartis UK Moves To London To Seek Its Life Sciences Digital Fortune

Novartis is to move its UK headquarters to London to be at the heart of the new technology and life sciences in the west of the city.

New Dawn At Novartis As Narasimhan Demands Breakthroughs

Vas Narasimhan says it’s not enough to develop drugs that are first- or best-in-class, they have to be transformational in the benefits they offer patients and society at large. CAR-T therapy Kymriah fits the bill.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC124510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel